TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease.

Vijaya Raj Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.